FDA approves the first vaccine to prevent meningococcal disease in infants and toddlers

Posted by Food and Drug Administration--Press Releases on Friday Apr 22, 2011 Under News

The U.S. Food and Drug Administration today approved the use of Menactra in children as young as 9 months for prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. Menactra already is approved for use in people ages 2 through 55 years.

Be Sociable, Share!

Comments are closed.